The expression of LC-3 is related to tumor suppression through angiogenesis in esophageal cancer

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Sakurai, Toshihide ^a   Okumura, Hiroshi ^a   Matsumoto, Masataka ^a   Uchikado, Yasuto ^a   Setoyama, Tetsuro ^a   Omoto, Itaru ^a   Owaki, Tetsuhiro ^a   Maemura, Kosei ^a   Ishigami, Sumiya ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Autophagy; Esophageal cancer; LC3

Indexed keywords

ENDOGLIN; MICROTUBULE ASSOCIATED PROCESS 1 LIGHT CHAIN 3; MICROTUBULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LIGHT CHAIN 3, HUMAN; TUMOR MARKER; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER PROGNOSIS; CARCINOGENESIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR INVASION; VERY ELDERLY; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891889594     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0701-x     Document Type: Article

References (32)

1. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6:463-77. (Pubitemid 38456176)
2. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12:1542-52. (Pubitemid 41553991)
3. Edinger AL, Thompson CB. Defective autophagy leads to cancer. Cancer Cell. 2003;4:422-4. (Pubitemid 38050038)
4. Colombo MI. Autophagy: a pathogen driven process. IUBMB Life. 2007;59:238-42. (Pubitemid 46763768)
5. Que X, Zou Z, Sun Q, Luby-Phelps K, Chenq P, Hoqan RN, et al. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell. 2007;128:931-46. (Pubitemid 46341412)
6. Kionsky DJ, Creqq JM, Dunn WA Jr, Emr SD, Sakai Y, Sandoval IV, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell. 2003;5:539-45. (Pubitemid 37243044)
7. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36:2503-18. (Pubitemid 39119762)
8. Tanida I, Minematsu-Ikequchi N, Ueno T, et al. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84-91.
9. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell. 2004;15:1101-11. (Pubitemid 38316219)
10. Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 2007;67:9677-84. (Pubitemid 47621214)
11. Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res. 2008;14:1931-7. (Pubitemid 351551101)
12. Saad RS, El-Gohary Y, Memari E, Liu YL, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic marker in esophageal adenocarcinoma. Hum Pathol. 2005;36:955-61. (Pubitemid 41253380)
13. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003;17:984-92. (Pubitemid 36676386)
14. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery. 2002;131:S109-13. (Pubitemid 34118625)
15. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9:777-94. (Pubitemid 43116546)
16. Goodsell DS. The molecular perspective: VEGF and angiogenesis. Stem Cells. 2003;21:118-9. (Pubitemid 36120373)
17. Sobin LH, Wittwkind CH. TNM Classification of Malignant Tumors, Internationale Union Against Cancer. 5th ed. New York: Wiley; 1997.
18. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 2008;99:1813-9. (Pubitemid 351448078)
19. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
20. Logan-Collins JM, Lowy AM, Robinson-Smith TM, Kumar S, Sussman JJ, James LE, et al. VEGF expression predicts survival in patients with peritoneal surface metastasis from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol. 2008;15:738-44.
21. Yoshioka A, Miyata H, Doki Y, Yamasaki M, Sohma I, Gotoh K, et al. LC-3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int J Oncol. 2008;33:461-8.
22. Semenza GL. Mitochondrial autophagy: life and breath of the cell. Autophagy. 2008;4:534-6. (Pubitemid 351705156)
23. Hanahan D, Weinberg RA. The hallmarks of Cancer. Cell. 2000;7:57-70. (Pubitemid 30046295)
24. Eisma RJ, Spiro JD, Kreutzer DL. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg. 1997;174:513-7. (Pubitemid 27486016)
25. Cavallaro U, Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol. 2000;50:63-70. (Pubitemid 32166291)
26. Chen L, Ren GS, Li F, Sun SQ. Expression of Livin and vascular endothelial growth factor in different clinical stage of human esophageal carcinoma. World J Gastroenterol. 2008;14:5749-54.
27. Brahimi-Horn MC, Chiche J, Pouyssequr J. Hypoxia and cancer. J Mol Med. 2007;85:1301-7. (Pubitemid 50004093)
28. Ahn CH, Jeonq EG, Lee JW, Kim MS, Kim SH, Kim SS, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 2007;115:1344-9.
29. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin1, Autophagy gene essential for early embryonic development, is a haploinsuffcient tumor suppressor. Proc Natl Acad Sci USA. 2003;100:15077-82. (Pubitemid 37518019)
30. Que X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin1 autophagy gene. J Clin Invest. 2003;112:1809-20. (Pubitemid 38063704)
31. Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008;68:9167-75.
32. Shen Y, Li DD, Wang LL, Denq R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy. 2008;4:1067-8. Technology